Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 762-765

  Sundar, Shyam ^a   Murray, Henry W ^b,c  

^a BANARAS HINDU UNIVERSITY   (India)

^b Department of Obstetrics Gynecology   (United States)

^c Box 130 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DERIVATIVE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONVALESCENCE; FEMALE; FEVER; HUMAN; INDIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

EID: 0030070831     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.762     Document Type: Article

References (5)

1. Dietze R, Fagundes SMS, Brito EF, et al. Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days. Trans R Soc Trop Med Hyg 1995;89:309-11.
2. Davidson RN, DiMartino L, Gradoni L, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994;87:75-81.
3. Freire-Silva E, Badaro F, Hafner A, et al. Amphotericin B liposomal therapy of visceral leishmaniasis [abstract]. Clin Infect Dis 1994;19:579.
4. Seaman J, Boer C, Wilkinson R, et al. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin Infect Dis 1995;21:188-93.
5. Mishra M, Biswas UK, Jha DN, Khan AB. Amphotericin B versus pentamidine in antimony-unresponsive kala-azar. Lancet 1992;340:1256-7.